This new Marketdata study examines the little-known but growing $1.3 billion niche healthcare market of medical foods. While medical foods are gaining more widespread acceptance, they remain poorly understood by patients, pharmacists and physicians. Most doctors in the U.S. have not heard of the term 'medical food' and don't know that it is a distinct, FDA-regulated category.
Medical foods are custom made liquid solutions, used enterally, to treat people with Alzheimers, depression, PTSD, osteoporosis, oncology patients, kidney dialysis patients, and infants with NEC/colitis. These products are obtained via pharmacies, by prescription—not retail. They are not regulated like drugs but must meet GRAS standards. The market has huge potential but is hampered by a lack of a trade association, a lack of exposure, and domination by a few large players.
This is a complete analysis of: market nature and definition, history and evolution, the major medical foods products/brands, how manufacturers operate, distribution channels, the role of physicians and pharmacists, market size and structure (2011, 2015, 2020 forecasts), government regulation and FDA actions/guidelines, major end-users and demand factors, potential for use in treating 10 major diseases/conditions, major market trends, functional foods market status, issues and obstacles, and more. Includes 29 in-depth competitor profiles and market outlooks by competitors. Includes 16 tables and charts.